Dermata Therapeutics Inc (DRMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,632 | 8,439 | 8,767 | 6,241 | 8,067 |
| TOTAL | $7,323 | $8,713 | $9,295 | $6,945 | $8,975 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $7,323 | $8,713 | $9,295 | $6,945 | $8,975 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 475 | 438 | 493 | 497 | 484 |
| Accrued Expenses | 442 | 245 | 714 | 426 | 1,021 |
| TOTAL | $917 | $683 | $1,207 | $923 | $1,504 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $917 | $683 | $1,207 | $923 | $1,504 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21 | 21 | 16 | 5 | 5 |
| Common Shares | 0 | 0 | 0 | 0 | 1 |
| Retained earnings | -51,254 | -49,535 | -47,833 | -45,593 | -43,924 |
| TOTAL | $6,407 | $8,030 | $8,088 | $6,022 | $7,471 |
| Total Liabilities And Equity | $7,323 | $8,713 | $9,295 | $6,945 | $8,975 |